SRCC (n = 34) | Non-SRCC (n = 33) | p | |
---|---|---|---|
Tumor recurrence | 8 (32%) | 10 (35.7%) | 0.776 |
Liver metastases | 1 (2.9%) | 6 (60%) | 0.096 |
Peritoneal carcinosis | 5 (62.5%) | 2 (6%) | |
Loco-regional | 2 (5.8%) | 2 (6%) | |
5-year survival | 16 (47.1%) | 17 (51.5%) | 0.715 |
Superficial cancer | 3 (100%) | 4 (80%) | 0.408 |
Invasive cancer | 13 (41.9%) | 13 (48.1%) | 0.635 |